Mustang Bio SVP of Finance & Corporate Controller resigns, consulting arrangement made

MUSTANG BIO, INC.

Brian Achenbach resigns as SVP of Finance & Corporate Controller, effective March 27, 2022.
Resignation is voluntary; no disagreement with Company on operations, financial reporting, or controls.
Consulting arrangement with Achenbach begins March 28, 2022, to ensure transition.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian Achenbach

Senior Vice President of Finance & Corporate Controller

MBIO · MUSTANG BIO, INC.

Effective: 2022-03-27
Filed: March 17, 2022, 7:59 PM ET

On March 11, 2022, Mr. Brian Achenbach notified Mustang Bio, Inc. (the “Company”) that he was resigning from his role as the Company’s Senior Vice President of Finance & Corporate Controller, effective March 27, 2022, to pursue an opportunity outside of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Achenbach resigned as Senior Vice President of Finance & Corporate Controller at MUSTANG BIO, INC..

Action: resigned
Role: Senior Vice President of Finance & Corporate Controller

Exact text from the filing

On March 11, 2022, Mr. Brian Achenbach notified Mustang Bio, Inc. (the “Company”) that he was resigning from his role as the Company’s Senior Vice President of Finance & Corporate Controller, effective March 27, 2022, to pursue an opportunity outside of the Company.

View on SEC.gov

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-035014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.